FIELD: medicine.
SUBSTANCE: invention represents versions of antibodies specifically binding to an extracellular domain of human CD43 or human CEA expressed by nonhematopoietic cancer cells. Said antibodies are characterised by amino acid sequences of either three heavy and light chain CDR, or amino acid sequences VH and VL. There are also presented an antibody conjugate with a cytotoxic agent; a host cell producing the antibody; a composition for nonhematopoietic cancer; a polynucleotide; an antibody expression vector.
EFFECT: versions of a method of treating nonhematopoietic cancer.
29 cl, 16 dwg, 6 tbl, 10 ex
Title |
Year |
Author |
Number |
ANTIBODIES RECOGNIZING CARBOHYDRATE-CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS OF APPLICATION |
2012 |
- Lin Rong-Khva
- Lin Leeven
- Lin Shikh-Jao
- Li Shu-Khua
|
RU2616868C2 |
ANTIBODIES RECOGNISING EPITOPE ON CD43 AND CEA EXPRESSED ON MALIGNANT CELLS AND METHODS FOR USING THEM |
2008 |
- Lin Shikh-Jao
- Lin Leeven
- Tsaj Ju-In
|
RU2528738C2 |
COVALENT DIANTIBODIES AND USE THEREOF |
2009 |
- Dzhonson Lesli S.
- Khuan Lin
|
RU2593720C2 |
CD43 ANTIBODIES AND USE THEREOF FOR TREATING CANCER |
2016 |
- Hong Kwon Pyo
- Yoon Sangsoon
- Koukoulas Irene
- Batori Vincent
- Cristiano Briony
- Wilson Jr David S
- Kopsidas George
|
RU2694903C1 |
BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47 |
2019 |
- Buatois, Vanessa
- Majocchi, Sara
- Strein, Klaus
|
RU2798246C2 |
COVALENT DIABODIES AND USE THEREOF |
2009 |
- Dzhonson Lesli S.
- Khuan Lin
|
RU2744176C2 |
TRISPECIFIC BINDING MOLECULES, WHICH SPECIFICALLY BIND ANTIGENS OF A VARIETY OF MALIGNANT TUMORS, AND METHODS OF USING THEM |
2015 |
- Bonvini, Ezio
- Moore, Paul, A.
- Li, Jonathan, C.
- Johnson, Leslie, S.
- Shah, Kalpana
|
RU2718692C2 |
ANTIBODIES TO THE RELATED CANCER-EMBRYONIC ANTIGEN CELL ADHESION MOLECULE (CEACAM) |
2012 |
- Markel Gal
- Ben Moshi Tekhila
- Sapir Yar
- Mendel Ilana
- Shakhter Yakob
- Ortenberg Rona
|
RU2650869C2 |
ANTI-PD-1 ANTIBODIES |
2017 |
- Jiang, Weidong
- Lin, Pei-Hua
- Tseng, Chi-Ling
|
RU2752832C2 |
COMBINED THERAPY BASED ON TUMOUR-TARGETED IMMUNOCYTOKINES CONTAINING VARIANT IL-2, AND ANTIBODIES TO HUMAN PD-L1 |
2015 |
- Umana Pablo
- Klajn Kristian
- Nikolini Valeriya G.
|
RU2710354C2 |